Atrium Therapeutics, Inc.

US$8.34As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:RNAHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE —
Biotechnology
Beta (5Y) 0.93
PE TTM —
TSR TTM —
Mkt cap US$142.7M
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
$11
27.99%
187.29%
Hold 9|3|12|10|3
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.10
0.10
0.11
0.11
20.12%
6.92%
21.38%
20.13%
Revenue$M
6.730
6.919
6.974
7.262
8.71%
8.64%
5.80%
5.60%
Peers (US$142.7M)
Cap (US$)
PE
148.4M
—
Capital
TTM
5Y
10Y
Leveragex
0.263
0.388
0.315
EBIT/Intx
1.022
0.253
0.231
Own earn%
(126.97)
(79.19)
(59.70)
Sh yield%
28.83
31.16
30.83
Owners
Insiders/Inst%
10.49
47.95
Short interest%
2.94
SBC / revenue%
5.76
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
10
Op margin range%
0–4
$1 testx
0.1
Incr. ROIC%
14